A Retrospective Pathology Review of Atypical Glandular Cells: hrHPV Status and Glandular Neoplastic Outcomes
- 2 October 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
Abstract
Objectives: To evaluate the relationship between high-risk human papillomavirus (hrHPV) status and glandular neoplastic outcomes in women with atypical glandular cells (AGC) and to characterize the clinicopathologic features of hrHPV-negative AGC. Methods: We evaluated 230,780 cervical cytology results collected from January 1, 2005 to June 1, 2017, identifying 698 (0.3%) AGC cases. Demographics, age at AGC diagnosis, Pap and reflex hrHPV results, and final AGC-related pathology were recorded. Associations between hrHPV status and glandular neoplastic outcomes were evaluated using the χ 2 test. Results: Among 698 women with AGC, 315 (45.1%) had hrHPV data, including 130 (41.3%) hrHPV-positive and 185 (58.7%) hrHPV-negative. The remaining 383 (54.9%) had no reflex hrHPV performed because of no squamous abnormalities. Of the 463 with pathology results, 49 (10.6%) had endometrial or endocervical cancer, including adenocarcinoma in situ. Of the 49, 8 (16.3%) were hrHPV-positive, 11 (22.4%) were hrHPV-negative, and 30 (61.3%) had unknown hrHPV. Of the 240 with hrHPV and pathology available, the incidence of glandular neoplastic lesions did not differ between hrHPV-negative and hrHPV-positive women (7.8% vs 8.1%; relative risk=1.04, 95% CI=0.43–2.48; p =.94). Women with glandular neoplastic lesions were significantly older at AGC diagnosis than those without neoplasia [mean (SD) age: 55.5 (16.1) vs 44.8 (11.6); p <.001]. Conclusions: AGC is associated with a significant risk of glandular neoplastic lesions, particularly among older women. hrHPV-negative AGC does not exclude clinically significant glandular neoplasia, supporting the diagnostic value of cervical cytology in AGC evaluation. These findings should be interpreted in the context of a historical, preprimary hrHPV screening practice.Keywords
This publication has 21 references indexed in Scilit:
- A Retrospective Analysis of 1151 Chinese Women With Atypical Glandular Cells: Impact of High‐Risk Human Papilloma Virus Status and Age on Cervical and Endometrial Neoplasia RiskDiagnostic Cytopathology, 2025
- The clinical significance of atypical glandular cells in Papanicolaou tests: changes in diagnostic patterns over 15 years at a single institutionJournal of the American Society of Cytopathology, 2025
- Cytology-histology correlation of atypical glandular cells on cervical Papanicolaou tests: A study of 628 casesJournal of the American Society of Cytopathology, 2024
- Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testingJournal of the American Society of Cytopathology, 2024
- Atypical glandular cells and development of cervical cancer: Population‐based cohort studyInternational Journal of Cancer, 2022
- Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020)Pathology, 2022
- Primary HPV screening for cervical cancerBest Practice & Research Clinical Obstetrics & Gynaecology, 2020
- Significance of high‐risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institutionCancer Cytopathology, 2016
- High‐risk HPV testing in the management of atypical glandular cells: A systematic review and meta‐analysisInternational Journal of Cancer, 2015
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsThe Lancet, 2014